• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Immatics NV (NQ: IMTX )

    11.82 -0.20 (-1.66%)
    Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 80,480
    Open 12.04
    Bid (Size) 11.16 (1)
    Ask (Size) 12.48 (1)
    Prev. Close 12.02
    Today's Range 11.76 - 12.07
    52wk Range 7.150 - 13.77
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Trading SMID Biotech Stocks In A Volatile Market
    Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... 
    Via Talk Markets
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga

    Performance

    YTD
    +10.26%
    +10.26%
    1 Month
    -2.56%
    -2.56%
    3 Month
    +12.14%
    +12.14%
    6 Month
    +15.49%
    +15.49%
    1 Year
    +3.05%
    +3.05%

    More News

    Read More
    Immatics Announces First Quarter 2024 Financial Results and Business Update
    From https://immatics.com/
    Via GlobeNewswire
    IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Why Immatics Shares Are Rising Today
    Via Benzinga
    Recap: Immatics Q1 Earnings
    Via Benzinga
    Why Immatics Stock Is Soaring Today
    Via The Motley Fool
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Immatics Announces Full Year 2023 Financial Results and Corporate Update
    From https://immatics.com/
    Via GlobeNewswire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Immatics Announces Pricing of $175 Million Public Offering
    From https://immatics.com/
    Via GlobeNewswire
    Immatics Announces Proposed Public Offering
    From https://immatics.com/
    Via GlobeNewswire
    Immatics Announces Third Quarter 2023 Financial Results and Business Update
    From https://immatics.com/
    Via GlobeNewswire
    Immatics Reports Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 Trial
    From https://immatics.com/
    Via GlobeNewswire
    Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy
    From https://immatics.com/
    Via GlobeNewswire
    Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
    Via ACCESSWIRE
    Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
    From https://immatics.com/
    Via GlobeNewswire
    Immatics Announces Second Quarter 2023 Financial Results and Business Update
    From https://immatics.com/
    Via GlobeNewswire
    Immatics Initiates Phase 1/2 Clinical Trial to Evaluate PRAME TCR Bispecific IMA402 in Patients with Advanced Solid Tumors
    From https://immatics.com/
    Via GlobeNewswire
    Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb
    From https://immatics.com/
    Via GlobeNewswire
    Top 5 Health Care Stocks That May Crash This Month
    Via Benzinga
    Immatics Announces First Quarter 2023 Financial Results and Business Update
    From https://immatics.com/
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    What's Going On With Immatics Shares Today
    Via Benzinga
    US Stocks Down; Chegg Crashes After Removing Guidance On ChatGPT Concerns
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.